These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28 related articles for article (PubMed ID: 34261912)
1. A normalized drug response metric improves accuracy and consistency of anticancer drug sensitivity quantification in cell-based screening. Gupta A; Gautam P; Wennerberg K; Aittokallio T Commun Biol; 2020 Jan; 3(1):42. PubMed ID: 31974521 [TBL] [Abstract][Full Text] [Related]
2. Selecting the appropriate indirect viability assay for 3D paper-based cultures: a data-driven study. Sitte ZR; Larson TS; McIntosh JC; Sinanian M; Lockett MR Analyst; 2023 May; 148(10):2245-2255. PubMed ID: 37073480 [TBL] [Abstract][Full Text] [Related]
3. HTS384 NCI60: The Next Phase of the NCI60 Screen. Kunkel MW; Coussens NP; Morris J; Taylor RC; Dexheimer TS; Jones EM; Doroshow JH; Teicher BA Cancer Res; 2024 Jun; ():. PubMed ID: 38861359 [TBL] [Abstract][Full Text] [Related]
4. Preparation and investigation of a novel combination of Shah HS; Zaib S; Khan I; Sliem MA; Alharbi O; Al-Ghorbani M; Jawad Z; Shahzadi K; Awan S Front Pharmacol; 2023; 14():1325498. PubMed ID: 38125886 [No Abstract] [Full Text] [Related]
5. Progeny Transfer Effects of Chitosan-Coated Cobalt Ferrite Nanoparticles. Shakil MS; Uddin MF; Morshed MR; Bhuiya MS; Alam M; Hossen MS; Niloy MS; Khan Shawan MMA; Hoque SM; Hasan MA ACS Omega; 2023 May; 8(17):15152-15159. PubMed ID: 37151486 [TBL] [Abstract][Full Text] [Related]
6. In vitro assays for anticancer drug discovery--a novel approach based on engineered mammalian cell lines. Gonzalez-Nicolini V; Fussenegger M Anticancer Drugs; 2005 Mar; 16(3):223-8. PubMed ID: 15711174 [TBL] [Abstract][Full Text] [Related]
7. A simple and reliable approach for assessing anticancer activity in vitro. López-Lázaro M Curr Med Chem; 2015; 22(11):1324-34. PubMed ID: 25666807 [TBL] [Abstract][Full Text] [Related]
8. Assay of anticancer drugs in tissue culture: comparison of a tetrazolium-based assay and a protein binding dye assay in short-term cultures derived from human malignant glioma. Haselsberger K; Peterson DC; Thomas DG; Darling JL Anticancer Drugs; 1996 May; 7(3):331-8. PubMed ID: 8792008 [TBL] [Abstract][Full Text] [Related]
9. Comparison of in vitro anticancer-drug-screening data generated with a tetrazolium assay versus a protein assay against a diverse panel of human tumor cell lines. Rubinstein LV; Shoemaker RH; Paull KD; Simon RM; Tosini S; Skehan P; Scudiero DA; Monks A; Boyd MR J Natl Cancer Inst; 1990 Jul; 82(13):1113-8. PubMed ID: 2359137 [TBL] [Abstract][Full Text] [Related]
10. Sulforhodamine B assay and chemosensitivity. Voigt W Methods Mol Med; 2005; 110():39-48. PubMed ID: 15901925 [TBL] [Abstract][Full Text] [Related]
11. A comparison of clonogenic, microtetrazolium and sulforhodamine B assays for determination of cisplatin cytotoxicity in human ovarian carcinoma cell lines. Perez RP; Godwin AK; Handel LM; Hamilton TC Eur J Cancer; 1993; 29A(3):395-9. PubMed ID: 8398340 [TBL] [Abstract][Full Text] [Related]